Studies have suggested that HER2 alterations may also serve as a resistance mechanism in up to 10% of EGFR-mutated NSCLC, pointing to a potential role for Bayer’s drug as a complement to anti ...

MoA Aggressive Allocation Fund earns a High Process Pillar rating. The most important driver of the rating is its parent firm's superior long-term risk-adjusted performance, as shown by the firm's ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

A catalytic mechanism is the sequence of elementary reactions by which a catalytic reaction proceeds. The behaviour of nanoconfined water can be very different from that of the bulk and is ...

Chemoimmunotherapy plus radiotherapy in advanced esophageal squamous-cell carcinoma. Pembro: pembrolizumab, mo: month. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...